BRIEF published on 08/06/2024 at 06:50, 2 years 1 month ago Galenica Reports Solid Growth Amid Challenging Market Conditions Sales Growth Galenica IT Infrastructure Pharmacy Market Generic Medicines
PRESS RELEASE published on 08/06/2024 at 06:45, 2 years 1 month ago Galenica achieves solid growth in a challenging market environment Galenica achieves solid growth in the first half of 2024 with 2.6% sales increase, confirming 2024 guidance. 10.7% EBIT growth seen, with various successes in healthcare services and market expansion Sales Growth Market Expansion Galenica EBIT Increase Healthcare Services
BRIEF published on 07/22/2024 at 18:16, 2 years 1 month ago Galenica Increases Stake in Redcare Pharmacy to 10% Investment Shareholding Redcare Pharmacy Galenica Pharmacy
PRESS RELEASE published on 07/22/2024 at 18:11, 2 years 1 month ago Galenica increases shareholding in Redcare Pharmacy to 10% Galenica increases stake in Redcare Pharmacy to 10% as part of strategic partnership, aiming for long-term investment benefits Strategic Partnership Investment Redcare Pharmacy Online Pharmacy Galenica
BRIEF published on 05/23/2024 at 06:50, 2 years 3 months ago Galenica stays the course with sales growth Pharmaceutical Growth Turnover Galenica Generics
PRESS RELEASE published on 05/23/2024 at 06:45, 2 years 3 months ago Galenica on track with sales growth Galenica Group reports 4.8% sales growth in the first four months of 2024, driven by positive pharmaceutical market development. Outlook for 2024 confirmed with sales growth between 3% and 5% Sales Growth Outlook 2024 Galenica Group Pharmaceutical Market
BRIEF published on 04/16/2024 at 18:10, 2 years 5 months ago Galenica Successfully Issues CHF 100 Million Bond Corporate Finance SIX Swiss Exchange Bond Issue Financial Stability Galenica AG
PRESS RELEASE published on 04/16/2024 at 18:05, 2 years 5 months ago Galenica successfully places a bond of over CHF 100 million Galenica successfully places a CHF 100 million fixed rate bond with a 7-year term and 1.65% annual coupon. The proceeds will be used for general corporate purposes, securing long-term financing Bond Long-term Financing Galenica AG CHF 100 Million Fixed Rate
BRIEF published on 04/10/2024 at 17:34, 2 years 5 months ago Shareholders of Galenica AG unanimously approve at the 7th Ordinary General Meeting Board Of Directors Dividend Annual Accounts General Assembly Galenica SA
PRESS RELEASE published on 04/10/2024 at 17:29, 2 years 5 months ago 7th Annual General Meeting: Shareholders approve all proposals Galenica Ltd.'s 7th Annual General Meeting sees approval of all proposals, including dividend of CHF 2.20 per share and re-election of Board of Directors members Board Of Directors Annual General Meeting Dividend Approval Galenica Ltd.
Published on 09/21/2026 at 15:45, 5 hours 44 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 7 hours 9 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 7 hours 24 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 7 hours 29 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 7 hours 44 minutes ago Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M
Published on 09/21/2026 at 20:34, 55 minutes ago BRANICKS Group AG: Regular interest payment on EUR 400 million bond to be made as scheduled – Completion of maturity extension imminent
Published on 09/21/2026 at 18:00, 3 hours 29 minutes ago Cham Swiss Properties places bond of CHF 100 million
Published on 09/21/2026 at 17:45, 3 hours 44 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 11-18 September 2026
Published on 09/21/2026 at 17:45, 3 hours 44 minutes ago Charwood Energy continues to grow at a strong pace. H1 revenue up +43% to €5.6m.
Published on 09/21/2026 at 17:00, 4 hours 29 minutes ago Menarini Group and NewAmsterdam Pharma Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
Published on 09/21/2026 at 18:19, 3 hours 10 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 3 hours 28 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 3 hours 43 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 07:00, 14 hours 29 minutes ago Peugeot Invest takes a stake in Mérieux NutriSciences
